1. Home
  2. QMCO vs AARD Comparison

QMCO vs AARD Comparison

Compare QMCO & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

N/A

Current Price

$6.93

Market Cap

99.5M

Sector

Technology

ML Signal

N/A

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

N/A

Current Price

$4.62

Market Cap

85.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QMCO
AARD
Founded
1980
2017
Country
United States
United States
Employees
N/A
40
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.5M
85.7M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
QMCO
AARD
Price
$6.93
$4.62
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$10.50
$15.29
AVG Volume (30 Days)
398.4K
235.6K
Earning Date
02-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$372,827,000.00
N/A
Revenue This Year
$0.32
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.65
N/A
52 Week Low
$4.19
$3.35
52 Week High
$15.33
$17.94

Technical Indicators

Market Signals
Indicator
QMCO
AARD
Relative Strength Index (RSI) 67.85 43.37
Support Level $6.64 $3.35
Resistance Level $8.27 $6.19
Average True Range (ATR) 0.56 0.28
MACD 0.21 0.34
Stochastic Oscillator 95.89 98.88

Price Performance

Historical Comparison
QMCO
AARD

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: